U.S. to ship 85% fewer J&J vaccine doses to states next week

The U.S. government will allocate nearly 85% fewer Johnson & Johnson COVID-19 vaccine doses to states next week, according to data from the Centers for Disease Control and Prevention (CDC), due to uneven production related in part to problems at a Baltimore manufacturing plant. A California health official told Reuters that the state's allocation will fall further to 22,400 doses in the week starting April 18.

Reuters | Washington DC | Updated: 09-04-2021 01:43 IST | Created: 09-04-2021 01:39 IST
U.S. to ship 85% fewer J&J vaccine doses to states next week
Representative Image Image Credit: Twitter(@SAgovnews)

The U.S. government will allocate nearly 85% fewer Johnson & Johnson COVID-19 vaccine doses to states next week, according to data from the Centers for Disease Control and Prevention (CDC), due to uneven production related in part to problems at a Baltimore manufacturing plant. Allocations will fall to 785,500 doses from 4.95 million doses this week. The data does not include a federal retail pharmacy program.

An official from the U.S. Department of Health and Human Services (HHS), who did not wish to be named, told Reuters that J&J released about 1.5 million doses to the U.S. government this week, compared with about 11 million doses last week. The allocation and distribution of COVID-19 vaccines is handled by the federal government. HHS expects J&J's supply to be uneven, the official said, but added that the company had promised it was on track to meet its commitment of delivering close to 100 million doses by the end of May.

J&J did not respond to requests for comment. J&J last month said it had delivered enough of its one-dose vaccine by the end of March to enable full vaccination of more than 20 million people. The company said it would be able to deliver an additional 24 million doses through April.

A New York Times report last week said that workers at an Emergent BioSolutions facility in Baltimore contracted to make both the AstraZeneca Plc and J&J vaccines, mixed up ingredients of the two shots, ruining 15 million J&J doses. The Baltimore facility has not been authorized by the U.S. Food and Drug Administration, and a federal health official told Reuters last week that no vaccines produced at the plant had gone into arms.

A report from last year posted by the FDA on Thursday showed that inspectors had flagged several issues at the plant in April 2020, before the company began making COVID-19 vaccines, including inadequate controls to prevent contamination, training problems, and other quality control issues. "We have worked and continue to work closely with the federal government in support of the COVID response," Emergent spokesman Matt Hartwig said in an email. "These FDA observations were addressed and reviewed in detail with FDA during their recent site visits in September 2020 and February 2021."

According to CDC data, California receives largest allotment of the J&J vaccine, followed by Texas and Florida. The vaccine allocation for California will be down by about 88%, with the state set to receive a maximum of 67,600 doses next week. A California health official told Reuters that the state's allocation will fall further to 22,400 doses in the week starting April 18.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Viral variants and vaccine nationalism pose two-pronged threat to Covid victory

... ...

Tracking Fintech during COVID-19: Harnessing power of technology

Its abundantly clear now that as fintech cements its place in the financial sector, accelerated further by the COVID-19 pandemic, it could open the sector to new possibilities by harnessing the power of technology to deliver financial ...

Tectonic turns: How technology shaped healthcare over the decades

Tracing an episodic evolution, with technology at the interface of human and his health....

World Water Day sees crises of inequality in countries both rich and poor

... ...

Videos

Latest News

Johnson & Johnson asked rival COVID-19 vaccine makers to probe clotting risks - WSJ

Johnson Johnson had reached out to rival COVID-19 vaccine makers to join in an effort to study the risks of blood clots, the Wall Street Journal reported on Friday, citing people familiar with the matter.AstraZeneca, which had been buffete...

Woman can't be denied right to be considered for employment because of nature of work: Kerala HC

The Kerala High Court on Friday observed that a woman who is fully qualified cannot be denied of her right to be considered for employment on the grounds that she is a woman and because the nature of the employment would require her to work...

U.S. broadcaster RFE/RL asks European court to defend it from Russian crackdown

U.S. broadcaster Radio Free EuropeRadio Liberty has appealed to the European Court of Human Rights to order Russian authorities to refrain from enforcing fines on its Moscow bureau that would cause irreversible harm. The U.S. multimedia new...

TN CM, Stalin greet Governor Banwarilal Purohit

Tamil Nadu Chief Minister K Palaniswami, Deputy Chief Minister O Panneerselvam, Telangana Governor Dr Tamilisai Soundararajan and DMK president M K Stalin greeted Governor Banwarilal Purohit on his birthday on Friday.The chief minister sent...

Give Feedback